Pathologists have an important role in the diagnosis of infectious disease (ID). In many cases, a definitive diagnosis can be made using cytopathology alone. However, several ancillary techniques can be used on cytological material to reach a specific diagnosis by identifying the causative agent and consequently defining the management of the patient. This review aims to present the effectiveness of the application of molecular studies on cytological material to diagnose IDs and discuss the advantages and disadvantages of the various molecular techniques according to the type of cytological specimen and the infectious agents. Diagn. Cytopathol. 2016;44:156-164. V C 2015 Wiley Periodicals, Inc.
Infectious diseases (ID) are well-acknowledged threats to global human health in the past and at present. Since the first report of Grieg and Gray in 1904, 1 that stated "the potential of fine-needle aspiration (FNA) in the diagnosis of ID," the role of cytopathology in ID has expanded enormously with the advances in molecular techniques. Cytopathologists are frequently the first to diagnose an ID, and cytopathology material can be used to follow the disease and monitor the response to the treatment. However, the diagnosis of ID and the specific causative agent based solely on the cytomorphology and traditional ancillary techniques has limitations and needs to be correlated with additional techniques including molecular methods.
The integration of molecular methods into the diagnosis of ID using cytology material requires educated personnel, facilities and set work flow designs, but most importantly the methods have to be standardized and performed in collaboration with a clinical microbiologist. It has been shown that costs will be reduced in the longterm by the use of molecular methods compared with conventional methods in the diagnosis of ID: patient outcome are improved, costs are reduced by the use of correct antimicrobials, and hospital stay times will be shortened reducing nosocomial infections. 2 In the literature, studies have focused on the diagnosis of granulomatous diseases using molecular methods on cytology specimens. This review contains comprehensive, up to date, and systematic information covering the use of molecular techniques to diagnose ID in gynecological and non-gynecological cytological material.
Molecular Methods
Molecular diagnostics of IDs are based particularly on nucleic acid assay methods. There are three main categories of nucleic acid test: amplified, non-amplified, and microarrays.
Amplified Nucleic Acid Techniques
Amplified DNA based methods are composed of three subcategories as target, signal, and probe amplification. The polymerase chain reaction (PCR) amplification-and hybridization-based approaches are the most widely used ones in amplified techniques (Fig. 1) . [3] [4] [5] Target amplification methods utilize post-amplification analysis where required.
PCR is the most common target amplification method to detect cultured and uncultured bacteria used currently in clinical practice. 6 Since 1985 many PCR amplification based techniques have been designed for bacterial detection and identification, including: competitive PCR, mostprobable number PCR (MPN-PCR), co-operational PCR, BIO-PCR, nested-PCR, and real-time PCR. Real-time PCR is the most useful and commonly used method because it is faster, has lower contamination risk and higher sensitivity, and has quantitative applications. PCR analysis can be applied directly to fresh material obtained from FNA, to liquid-based cytology materials and even to cells scraped from slides. 7 DNA is amplified by repeating three major steps, which are denaturation of the DNA template, annealing of oligonucleotide primers, and extension of the primers by DNA polymerase, to produce a copy of the target gene. 3 To yield high quality DNA is definitely the most critical step.
Unlike PCR, transcription based methods (TBM) and strand displacement amplification (SDA) are isothermal techniques that do not require a thermal cycler. 8 Nucleic acid sequence-based amplification (NASBA) and transcription-mediated amplification (TMA) are TBM in which the RNA target is reverse transcribed into cDNA and then RNA copies are synthesized with a RNA polymerase. Both TBM and SDA have been used particularly for sexually transmitted diseases (e.g., Chlamydia trachomatis and Neisseria gonorrheae), although false-positive results with this technique have been reported in the literature. 8, 9 Signal amplification assays are correlated with the amount of the target sequence in the cytological material. 4, 8 bDNA assays usually are used to detect HCV, HBV, and HIV-1 blood levels and are based on the balance between capture probe bDNA assays and the quantitation of the microorganism. 3, 8 Loop-mediated isothermal amplification (LAMP) is a one-step technique which is very similar to SDA and has been developed for cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), BK virus, and human papillomavirus (HPV). 8 In the last two decades, hybrid capture has become a popular technique applicable to gynecological cytology specimens. Briefly, the method entails the reaction between DNA-RNA hybrids and anti-hybrid antibodies, with a luminometer measuring the light emitted. 3, 8 Chlamydia trachomatis, Neisseria gonorrheae, CMV, and particularly HPV are the common agents detected by this method. 3 The most important benefit of amplification methods is the requirement for low target copy numbers within a direct specimen. On the other hand, contamination is the main problem of the amplified techniques when compared with microarrays and non-amplified methods. 3, 10 Also, the evaluation of the sensitivity of each specimen type and the setting up of a number of positive and negative controls for each diagnostic run are vital for rendering standardization, which is sine qua non for molecular studies.
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Microarrays
Microarrays, multiplex nucleic acid amplification techniques, and mass spectrometry are multiparameter assay techniques that provides rapid diagnoses with a decreased contamination risk, low cost, high sensitivity/specificity, and rapid kinetics through the use of a closed-tube systems.
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Non-Amplified Nucleic Acid Techniques
The well-known format is probe hybridization comprised of liquid phase, solid phase, and in situ hybridization. Different species can be detected by in-situ hybridization in the one clinical sample in the same run through use of multiple probes labeled with different fluorescent dyes. 9 It is a very commonly used and rapid technique with the four "S" advantages: safe, simple, specific, and sensitive in detecting and identifying the microorganisms directly from the clinical specimen such as a smear. The presence of unbound probes and the nonspecific binding of the probe to non-target microorganisms may give false results with this technique. 13 Due to the high contamination risk of upper airway flora, cytology specimens may show diagnostic limitations. As the most common agent of CAP, Streptococcus pneumonia is a fastidious bacterium which needs special environmental and nutritional conditions to culture, and so molecular methods are recommended for its detection. The concentration of the bacteria in the cytological specimen is a significant step in deciding whether it is a pathogen and which is the appropriate molecular method to diagnose the CAP. Streptococcus pneumoniae, Mycoplasma pneumonia, Staphylococcus aureus, and Chlamydia pneumoniae among others, should be detected at a certain concentration before they are considered a pathogen. However, even trace amounts of Mycobacterium tuberculosis, Bacillus anthracis, Legionella, endemic fungi, Yersinia pestis, and Francisella tularensis are assumed pathogenic regardless of the concentration. Real-time PCR is the best method for use in this situation because is also quantitative.
Invasive aspergillosis (IA) is a significant cause of death in cancer patients. The concentration threshold is also important in the diagnosis of aspergillosis, and a quantitative PCR (real-time PCR) is recommended to differentiate colonization from infection. Sun et al. reported the sensitivity of 95% and specificity of 95% in the diagnosis of Aspergillus species with PCR. 14 Paracoccidioides brasiliensis can cause a systemic mycosis agent that is not limited to immune-compromised patients. It is only seen in Latin America and is accepted as endemic particularly in Brasil. Histoplasma spp. and Coccidioides immitis can be misinterpreted as paracoccidioidomycosis. LAMP was suggested as a highly specific and sensitive method to identify the target P. brasiliensis P43 gene in sputa. [15] [16] [17] Coccidioides immitis and Blastomyces dermatitidis are other examples of systemic fungal infections that can be misdiagnosed clinically and morphologically, and specifically diagnosed on DNA probes specific for unique RNA sequences.
Mycobacterium africanum and M. canetti mainly seen in African countries cause human tuberculosis and share almost identical genomes, called "the mycobacterium tuberculosis complex organisms" (MTC), along with Mycobacterium tuberculosis and Mycobacterium bovis which are the most common members of this group in all developing countries. However, it is almost impossible to differentiate these mycobacteria using conventional methods. Mycobacterium bovis is an increasing threat particularly in Asia, Latin America and the HIV-infected patient group and can cause pulmonary and extrapulmonary tuberculosis in humans. 18 Bakshi et al. showed that it is possible to distinguish M. bovis from M. tuberculosis using a multiplex PCR based on the absence of a 12.7 kb fragment in M. bovis which is present in M. tuberculosis. 18 Chen et al. using the microsphere based multiplex assay in human sputum reported high identification rates to separate M. tuberculosis and M. bovis species, 98.9% and 91.9%, respectively. 19 Neonakis et al. detected M. tuberculosis with 88.2% sensitivity and 99% specificity by using LAMP in clinical specimens. As in the study of Iwamoto et al. and Aryan et al. LAMP has been established as a sensitive, rapid, and low-cost method for typical and atypical mycobacteria including M. tuberculosis and M. bovis (including M. bovis BCG), and the less common species M. africanum, M. microti, M. canetti, M. caprae, and M. pinnipedii in clinical samples. [20] [21] [22] There are other applications of real-time PCR to detect infectious agents in respiratory cytological samples that are discussed further in the section on FNA. Effusions. Chronic pericardial or pleural non-malignant effusions need to be analyzed for possible infection, the most common of which is tuberculosis. The benefits of PCR and usefulness of DNA PCR in diagnosing tuberculosis are well documented in the literature. 23, 24 Urine. BKV and John Cunningham virus (JCV) are the human polyoma viruses that are responsible of primary infection in almost 80% of the healthy population. After a latency period in the genitourinary tract including kidneys, viruses may be reactivated in immunodeficiency conditions such as HIV-infected or kidney transplant patients. Specific cytomorphologic findings, including Decoy cells, may be seen in 4% of urine samples. The studies based on PCR and particularly nested-PCR (diagnostic accuracy 56%) from urine specimens were reported as the most sensitive methods to detect polyomavirus infections and identify as the causative agent BKV or JCV. [25] [26] [27] Cerebrospinal Fluid (CSF). PCR, NASBA, and DNA branched assays have been used successfully to detect both RNA and DNA viruses in CSF for diagnosing viral encephalitis. The sensitivity of these techniques depends on the amount of the CSF sample ranging from 30 to 100-200 mL. Real time and nested PCR have high utility with the various primers for pan-herpesvirus assays in the detection of HSV-1, HSV-2, VZV, CMV and Epstein-Barr virus (EBV), and human herpesvirus-6 (HHV-6) in various combinations. [28] [29] [30] These assays are proven as clinically useful in the assessment of HIV patients presenting with a CNS disease, since multiple herpes viruses are capable of causing neurologic symptoms in this subset of patients. HSV-1 and 22, EBV, and VZV are the most common agents of sporadic viral encephalitis and Multiplex PCR Diagnostic Cytopathology DOI 10.1002/dc assays may be the best method to detect these agents in a single CSF specimen. 28 Fine-Needle Aspiration Cytology (FNAC) Lymph Node. It is commonly assumed that M. tuberculosis is the commonest cause of lymphadenitis, but PCR studies have shown that Bartonella henselae is the most common agent in both adults and children, presenting mostly as Cat Scratch Disease (CSD), although this is dependent on the population studied. 31 Avidor et al. showed that FNAC specimens for cytologic evaluation and PCR testing has a 94% sensitivity for the diagnosis of CSD, while culture, Warthin Starry silver impregnation stain and other stains offer low sensitivity. 32 Fenollar et al. emphasized that sequencing and hybridization techniques particularly are successful in identifying the species of Bartonella infection with visceral involvement such as bacillary angiomatosis, peliosis hepatitis, and CSD. 6 Extrapulmonary tuberculosis (EPTBC) is a widespread form of tuberculosis and most commonly presents in head and neck lymph nodes. FNAC is the first choice for the diagnosis, but early in the infection and in the absence of typical granulomas and or caseous necrosis and the frequent absence of acid fast bacilli the diagnosis may not be able to be made, and the distinction from other granulomatous entities including atypical mycobacteria on morphology alone may not be possible. Even the classical cytomorphology of EPTBC has lower sensitivity or specificity with FNAC associated with the traditional methods. The sensitivity of the Ziehl-Neelsen stain is reported as 20% up to 43% for diagnosing and monitoring the treatment of EPTBC. 33 Culture is regarded as the "gold standard" but needs 6-12 weeks and should be performed in a biosafety level 3 faculty. 34 Unfortunately, time is the most important factor in the diagnosis of an ID, particularly in immunocompromised conditions such as AIDS. In the study of Goel et al. nucleic acid testing (NAA) positivity for mycobacterial infection was reported in 72%-73% in fresh aspirates, regardless of the presence or absence of AFB. 34 Based on the study of Pruhit et al. PCR provided high sensitivity, specificity, and positive and negative predictive values (85%, 95%, 96%, and 59%, respectively) by using unstained air-dried cytology smears in 98 cases for the early and specific diagnosis of EPTBC. In the same study, Ziehl-Neelsen stain and culture was able to detect mycobacteria in 15.3%-24.4% of cases. 35 Due to the differences in treatment of typical, atypical mycobacteriosis, and the other granulomatous conditions, it is crucial to detect and identify bacteria with a high diagnostic accuracy.
Toxoplasma gondii may cause a suppurative lymphadenitis localized in posterior cervical lymph nodes. FNAC is very useful to distinguish this infection from malignant lymphoma and PCR can identify the protozoon.
Biological and clinical differences between HPVrelated and HPV non-related head and neck squamous cell carcinoma (HNSCC) effect the target therapy, response, and or resistance to the therapy as well as the prognosis. Differentiating HPV related from non-related SCC based solely on morphology is impossible and the molecular test has become best practice over the past few years. 36, 37 HPV16 is the commonest serotype found in 75%-92% of HPV-related HNSCC. Methods for detecting HPV use different targets such as, HPV DNA, HPV RNA, E6 E7 viral oncoproteins, and P16 as cellular protein. PCR based amplifications and DNA in situ hybridizations are used routinely, and the latter is very practical and allows visualization of the cells with high risk (HR) HPV DNA making the method highly specific. On the other hand, PCR based amplification methods (discussed in the gynecology part of this review) are much more sensitive and specific, but less practical. Although PCR, DNA in situ hybridization, and hybrid capture II and the Cervista technique (able to detect 14 sero-types) show variability in sensitivity and specificity, these methods have been successfully used to detect HR HPV in cytological material, even in the necrosis found in FNA material of Head and Neck metastases. [36] [37] [38] [39] In the prospective study of Baldassari et al. HR-HPV detection-genotyping performed on the FNA material from metastatic SCC in lymph nodes using the Roche Cobas 4800 system showed a sensitivity of 90% which is greater than studies using hybrid capture II and the Cervista technique which usually give high specificity but low sensitivity. 40 Lung. The opportunistic infections in immune compromised patients including HIV positive, cancer, and posttransplant patients, may mimic lung malignancies. Pneumocystis jiroveci is a major pathogen and can involve extrapulmonary sites including liver, spleen, skin, and pleural effusions. Specific diagnosis is based mainly on respiratory cytology materials. Bronchiolo-alveolar lavage (BAL) has a diagnostic yield of 97%-100%, superior to sputum with a specificity of 100% and sensitivity of 55% in the diagnosis of P. jiroveci. 41 Invasive procedures such as BAL and transthoracic FNAC may yield better diagnoses. Quantitative PCR (RT-PCR) and nested PCR are the widespread techniques now used in the diagnosis of pneumocystis pneumonia, and RT-PCR can differentiate colonization from infection in non-HIV patients. Both techniques have shown high specificity and sensitivity rates in many articles. [42] [43] [44] Histoplasma capsulatum, Cryptococcus neoformans, and Cryptococcus gattii may cause cavitating or solid lesions often large in size that can be misdiagnosed is lung malignancies. Mycobacterial infection (tuberculosis) of respiratory samples may be heralded by finding granulomatous inflammation with or without necrosis. FNA material is suitable for both traditional and molecular diagnostic methods. A combination of acid fast stain with PCR has high sensitivity (84%) and specificity (100%). 41 Many studies have focused particularly on realtime and nested-PCR and sputum and BAL samples a well as FNA. 45, 46 Viral pulmonary infections, such as CMV, Respiratory Syncytial Virus, and Herpes simplex, can also be confirmed using molecular tests on cytological samples. Skin. Buruli ulcer is an ID of skin presenting with a painless nodule, a firm plaque or an edematous lesion in children aged 15 years or younger and is caused by Mycobacterium ulcerans. It is common in over 30 countries worldwide, particularly humid tropical areas in West Africa. 47 Edyani et al. proved that FNAC is an effective diagnostic tool using the PCR technique, and that higher diagnostic accuracy was achieved using samples from nonulcerated compared with ulcerated lesions. 48 The application of PCR to the FNAC samples utilizing 21-gauge needles yielded 86% sensitivity compared with culture with 44% and microscopy with 26% as demonstrated by Phillips et al. 47 Real-time PCR has been suggested for detection, quantification and identification of Leishmania species in clinical samples. 49 Traditional methods yield 17% positivity in the patients with mucosal leishmaniasis while PCR achieved 71% positivity in the study of Tavares. 49 
Applications in Gynecological Cytology
The introduction of liquid-based cytology (LBC) in routine gynecological cytology produced better quality preparations for cytomorphology and the potential to perform complementary molecular assessment on residual material, particularly molecular tests for HR-HPV detection in cervical cancer prevention programs. The HR-HPV test increases the sensitivity of the "Pap test," and can achieve an acceptable specificity when used alone. 50 
HPV Test and Cervical Cancer Screening
The introduction of HPV test for primary cervical cancer screening has been contentious, but recent studies suggest that HPV tests can be used for this purpose. 51 The rational that supports the use of HPV testing in cervical cancer prevention is that the presence of HPV is necessary for cervical cancer development, 52 and therefore a negative HPV test excludes the development of highgrade lesions. The age to start HPV test screening has been debated but it should be set so as to avoid unnecessary tests while still reaching acceptable levels in detecting CIN2 lesions. Women aged 30 year's benefit the most with HPV-based screening. It is also critical to validate the HPV tests considered for use, which must have a sensitivity for CIN2detection equal or 90% and a specificity not <98%.
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A plethora of HPV tests have been developed in recent years, and choice of a specific test depends on a number of requisites that range from high performance indexes, to the workload capacity, local commercial concerns and to equipment maintenance, logistical issues, training, and cost. The majority of the tests target DNA as does the doyen Hybrid Capture technology; while others target RNA, for example, the NorChip PreTect HPV-Proofer. The important issue, however, is to identify hrHPV with high clinical sensitivity and acceptable specificity. Cuzick and colleagues 54 compared the performance of six hrHPV tests commercially available: Hybrid Capture 2 (Qiagen, Germany), Cobas 4800 HPV Test (Roche, The United States), Abbot RealTime High Risk HPV Assay (Abbot, Germany), BD HPV Test (BD Diagnostic, The United States), PreTect HPV-Proofer (NorChip, Norway), and APTIMA (Gen-Probe, The United States). Details on the HPV tests system are depicted in Table I . The authors 54 Recently, Nolte et al. designed a comparison study of performance characteristics of Aptima and Cervista HPV tests: Aptima HPV test was found to be as Cervista, however, specificity was higher compare to Cervista in the detection of hrHPV in cervical cytology specimens. 55 Most studies have shown that the RNA based assay APTIMA system has high specificity and sensitivity compared with the other assays. 56 The performance of the DNA-based assays was quite similar with a slightly lower positivity rate for the Abbott system in the group of women who had tested negative in the Pap test. Both RNA-based tests had lower performances in HPV detection in comparison with the DNA tests, but NorChip had significantly lower performance even when compared with the APTIMA test. All cases categorized as CIN3 were positive in all tests, with the exception of one case which tested negative in the Abbott assay and five negative in the NorChip test. 54 However, the main aim is to show not only transient infections which in most cases are self-limited but also integrated hrHPV viral infections which lead to squamous dysplasia and neoplasia. 56 APTIMA demonstrates the overexpression with the E6 and E7 mRNA of hrHPV. The viral genes E6 and E7 may inactivate tumor suppressor genes (P53 and pRB) during the integration into the host genome and activate the carcinogenesis process. 57 In Sauter et al. the authors reported 21% and 90% decreased colposcopy referral and QNS (quantity not sufficient) rates, respectively, with APTIMA compared with HC2. 56 APTIMA is the most well-known RNA based detection assay that detects the 16 hrHPV subtypes but cannot differentiate specifically between them, 56 and the clinical evaluation of APTIMA HPV RNA (CLEAR) trial showed other limitations including cross-reactivity with the lowrisk HPV subtypes 26, 67, 70, 82 , and crosscontamination of samples 58 59 However, HC2 does not have an internal control and may show cross-reaction with some low risk HPV subtypes representing limitations despite its high clinical sensitivity. 58 Cervista uses the "Invader chemistry" (Hologic) and targets the HPV L1 gene. Cervista has an internal control with the patient specimen, but some studies have shown that it has distinctive limitations during processing with the glacial acetic acid. 60 Cobas is a PCR amplification test studied in 47,000 women in the ATHENA trial (Addressing the Need for Advanced HPV Diagnostics) which demonstrated excellent performance. 61 The U.S. Food and Drug Administration 62 approved the Cobas 4,800 HPV Test for use in primary screening in women 25 years. As the first prospective U.S. screening study, the ATHENA 63 end-results have very recently been published and it has been incorporated into current guidelines (http://dx.doi. org/10.1016/j.ygyno.2014.11.076.). This recommendation is important because this is a paradigm change for cervical cancer prevention. The adoption of molecular testing for primary cervical cancer screening has been seriously considered by many public authorities in European Countries, 64, 65 where cytology-based screening has been successfully implemented.
Larsson et al. performed the extended genotyping approach with Anyplex II HPV28, which detects 28 genotypes and the human gene beta-globulin HBB in two multiplex reactions, and CLART HPV2 (Genomica), which detects 35 genotypes and the human gene CTFR in one reaction targeting the L1 region of the virus, using archival clinical samples and found both were suitable alternative methods even in the presence of minor intraassay differences. 66 Finally, the hrHPV assay test can be used on residual liquid media material importantly in patients, who have had cervical conization for high grade lesions, 67 to determine hrHPV positive patients who are at risk of recurrence after surgery. The hrHPV test can also be used as a reflex test in cases of cytological atypia of undetermined significance (ASC-US) 68 to improve the detection of high grade lesions. Liquid media also can be used in the methylation marker test (CADM1/MAL methylation analysis) as a triage test in hrHPV positive women in the presence of CIN2 and CIN3. 69 
The Use of Liquid Medium for Other Genital Infections
Many of the microorganisms usually found in cervicalvaginal region are also detectable in liquid media using different molecular tests, which are easy to perform and generate results generally comparable to the traditional, but generally time consuming, assays such as vaginal sample cultures or conventional PCR. One of the most interesting advances are the very robust Chlamydia and gonorrhea organisms tests, performed in a "combo fashion" system (Table II) .
Liquid-based cytology medium samples can be used to preserve urine similarly to vaginal material for various tests including the successful identification of the Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum, in female and male patients. 70 Importantly, in house PCR molecular methods applied to the residual material from liquid-based cytology medium have efficiently recognized Herpes simplex virus and Cytomegalovirus. 71, 72 Closing Remarks
The use of molecular methods on cytological material is a milestone in the specific diagnosis of the ID. The integration of nucleic acid testing methods with cytopathology provides improved diagnostic protocols and in some cases a correct diagnosis more rapidly for life saving treatment. However, it is necessary to systematically assess "which" test to utilize, "where" to use it, and "how" to integrate the nucleic acid testing methods with the cytomorphological diagnosis to maximize the diagnostic potential and cost benefit in the challenging diagnosis of it is. In addition to the classical cytology smear preparation, the introduction of liquid-based cytology in both gynecological and non-gynecological investigations has opened up new horizons in terms of ID diagnoses, primary screening options, and post-treatment follow-up methods, demonstrating clear advantages for clinicians and patients.
